Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 43 EP applications Antoine Courgeon has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12723748

ANTIPYRETICS TO ENHANCE TOLERABILITY OF VESICLE-BASED VACCINES

IPC classification:
A61K 38/16, A61K 35/74, A61K 31/167, A61P 43/00
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12702153

RSV IMMUNIZATION REGIMEN

IPC classification:
A61P 31/14, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12743037

COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

IPC classification:
G01N 33/53, C12Q 1/68, C07K 14/005
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12718460

ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12722057

PRE-FUSION RSV F ANTIGENS

IPC classification:
C07K 14/135
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12753488

ADJUVANTED FORMULATIONS OF STAPHYLOCOCCUS AUREUS ANTIGENS

IPC classification:
A61K 39/085, A61P 31/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12797981

ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12778013

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

IPC classification:
A61K 39/25, A61K 39/245, C12N 15/86
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12788647

CARRIER MOLECULE COMPRISING A SPR0096 AND A SPR2021 ANTIGEN

IPC classification:
A61K 47/48, A61K 39/385, A61K 39/095, A61K 39/09, A61P 31/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12769787

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 39/39, A61K 9/127, A61K 9/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12735420

IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/295, A61K 39/12, A61K 39/00, C07K 14/045, C07K 14/015
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
The patent has been granted
EP12738679

LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

IPC classification:
A61K 39/39, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12781365

FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

IPC classification:
A61K 39/05
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12738311

OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

IPC classification:
A61K 39/00, A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12743273

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 47/24, A61K 47/06, A61K 39/00, A61K 9/107
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12818607

ASSAY FOR INFLUENZA VIRUS HEMAGGLUTININS

IPC classification:
G01N 33/569
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12812257

STABLE COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11811574

ADJUVANTED COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEINS

IPC classification:
A61K 39/095, A61P 31/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13703562

PROMOTERS FOR INCREASED PROTEIN EXPRESSION IN MENINGOCOCCUS

IPC classification:
C12N 15/74, C12N 15/63
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
The patent has been granted
EP13710321

ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS

IPC classification:
A61K 39/39, A61K 39/09, A61K 33/42, A61K 33/08, A61K 31/66, A61K 31/4375
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13708414

COMBINATION VACCINES WITH TLR4 AGONISTS

IPC classification:
A61K 39/116, A61K 39/08, A61K 39/05
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13709394

ADJUVANTED FORMULATIONS OF RABIES VIRUS IMMUNOGENS

IPC classification:
A61K 39/395, C07D 487/04, C07D 471/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13708142

IMMUNOLOGICALLY USEFUL ARGININE SALTS

IPC classification:
A61K 31/4375, C07D 471/04, A61P 37/04
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
PATENT GRANTED
EP13724265

MENINGOCOCCUS SEROGROUP X CONJUGATE

IPC classification:
A61K 47/48, A61K 39/095, G01N 30/96, G01N 30/06, A61P 31/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13726225

IMPROVED SAFETY TESTING

IPC classification:
A61K 39/12, C12Q 1/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION WITHDRAWN
EP13747515

VACCINES FOR SEROGROUP X MENINGOCOCCUS

IPC classification:
A61K 39/095
Applicant:
Institut Pasteur
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13729364

STABILIZED GP120

IPC classification:
A61K 39/21, C07K 14/005
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13736518

COMPLEXES OF CYTOMEGALOVIRUS PROTEINS

IPC classification:
A61K 39/245, C12N 7/02, C07K 14/045
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13732536

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/21
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13758802

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085, A61K 38/16, C07K 14/315, C07K 14/31, C07K 1/113
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13758801

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085, A61K 38/16, C07K 14/315, C07K 1/113
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13753327

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13771400

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085, C07K 14/31
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13758877

COMBINATION VACCINES WITH SEROGROUP B MENINGOCOCCUS AND D/T/P

IPC classification:
A61K 39/095
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP11804867

FLOW CYTOMETRY ANALYSIS OF MATERIALS ADSORBED TO METAL SALTS

IPC classification:
G01N 33/537, G01N 33/84, G01N 33/68, G01N 33/569
Applicant:
Novartis AG
Agent:
Antoine Courgeon, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14177182

RSVF trimerization domains

IPC classification:
C07K 14/005, C07K 19/00, A61K 39/155
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14191385

Mammalian cells expressing cytomegalovirus antigens

IPC classification:
C12N 5/071, A61K 39/245, C07K 14/005
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14196854

Cytomegalovirus antigens

IPC classification:
A61K 39/12, A61K 39/245, C07K 14/005
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14199441

Purification of streptococcal capsular polysaccharide

IPC classification:
A61K 39/09, C08B 37/00
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION REFUSED
EP15152221

Cytomegalovirus antigens and uses thereof

IPC classification:
C07K 14/005, A61K 39/245, C07K 16/08
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION PUBLISHED
EP15152415

CMV ANTIGENS AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/08, C07K 14/005, A61K 39/245
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION PUBLISHED
EP12704573

ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

IPC classification:
A61K 31/4375, A61K 47/44, A61K 47/32, A61K 47/26, A61K 9/107
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP15157068

FLAVIVIRUS REPLICONS

IPC classification:
C12N 15/86
Applicant:
Novartis AG
Agent:
Ralf Badur, Novartis Pharma AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature